CHOLSTYQ™
S4 Reg. No.: 56/5.11/0094
CHOLSTYQ™
Solution for injection (IV)
0,5 mg/ml glycopyrronium bromide and 2,5 mg/ml neostigmine metilsulfate
HYPOPRESS™ 10 mg/ml
S4 Reg. No.: 55/6.1/0353
HYPOPRESS™ 10 mg/ml
Solution for injection or infusion
10 mg/ml phenylephrine hydrochloride
SINORA™
0,16 mg/ml
S4 Reg. No.: 56/5.1/0110
SINORA™ 0,16 mg/ml
Ready to use solution for infusion, no need to dilute
Each 50 ml vial contains 16 mg of noradrenaline tartrate corresponding to 8 mg of noradrenaline base
SINORA™
4 mg/4 ml
S4 Reg. No.: 56/5.1/0112
SINORA™ 4 mg/4 ml
Concentrate for solution for infusion
2 mg/ml noradrenaline tartrate equivalent to 1 mg/ml noradrenaline
BACENTRA INTRATHECAL™
S4 Reg. No.: 54/2.10/0366
BACENTRA INTRATHECAL™
0,05 mg/ml
Solution for injection
0,05 mg/ml Baclofen
S4 Reg. No.: 54/2.10/0367
BACENTRA INTRATHECAL™
0,5 mg/ml
Solution for infusion
0,5 mg/ml Baclofen
S4 Reg. No.: 54/2.10/0368
BACENTRA INTRATHECAL™
2 mg/ml
Solution for infusion
2 mg/ml Baclofen
MISYO™ 10 mg/ml
S6 Reg. No.: 55/2.9/0741
MISYO™ 10 mg/ml
Oral solution
Each 1 ml of the oral solution contains 10 mg of methadone hydrochloride